Economic Burden Due to COVID-19 in a Colombian Caribbean State, 2020 and 2021

Overview

Journal Epidemiol Serv Saude

Date 2024 Jul 10

PMID 38985065

Authors

Fernando Salcedo-Mejia

Lina Moyano-Tamara

Josefina Zakzuk

Ana Milena Lozano

Hector Serrano-Coll

Bertha Gastelbondo

Salim Mattar Velilla

Nelson Rafael Alvis Zakzuk

Nelson J Alvis-Zakzuk

Nelson Alvis Guzman

Affiliations

Soon will be listed here.

Abstract

Objective: To estimate the economic burden associated with COVID-19 in Córdoba, Colombia, 2020 and 2021.

Methods: Economic burden study. Direct costs were analyzed from the third-party payer perspective using healthcare administrative databases and interviews from a cohort of confirmed COVID-19 cases from Córdoba. Costing aggregation was performed by the bottom-up method. Indirect costs were estimated using the productivity loss approach. Contrast tests and statistical models were estimated at 5% significance.

Results: We studied 1,800 COVID-19 cases. The average economic cost of COVID-19 per episode was estimated at US$ 2,519 (95%CI 1,980;3,047). The direct medical cost component accounted for 92.9% of the total; out-of-pocket and indirect costs accounted for 2% and 5.1%, respectively.

Conclusion: COVID-19 economic cost was mainly due to direct medical costs. This study provided evidence of the economic burden faced by households due to COVID-19, with the most vulnerable households bearing much of the burden on their income.

References

Bartsch S, Ferguson M, McKinnell J, OShea K, Wedlock P, Siegmund S . The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States. Health Aff (Millwood). 2020; 39(6):927-935. PMC: 11027994. DOI: 10.1377/hlthaff.2020.00426. View

Alvis-Zakzuk N, Florez-Tanus A, Diaz-Jimenez D, Chaparro-Narvaez P, Castaneda-Orjuela C, De la Hoz-Restrepo F . How Expensive Are Hospitalizations by COVID-19? Evidence From Colombia. Value Health Reg Issues. 2022; 31:127-133. PMC: 9167033. DOI: 10.1016/j.vhri.2022.04.005. View

Li X, Jin F, Zhang J, Deng Y, Shu W, Qin J . Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis. Infect Dis Poverty. 2020; 9(1):78. PMC: 7322714. DOI: 10.1186/s40249-020-00689-0. View

Edejer T, Hanssen O, Mirelman A, Verboom P, Lolong G, Watson O . Projected health-care resource needs for an effective response to COVID-19 in 73 low-income and middle-income countries: a modelling study. Lancet Glob Health. 2020; 8(11):e1372-e1379. PMC: 7480983. DOI: 10.1016/S2214-109X(20)30383-1. View

Jabakhanji S, Sorensen J, Valentelyte G, Burke L, McElroy B, Murphy A . Assessing direct healthcare costs when restricted to self-reported data: a scoping review. Health Econ Rev. 2021; 11(1):35. PMC: 8444520. DOI: 10.1186/s13561-021-00330-2. View

Moran J, Solomon P, Peisach A, Martin J . New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007; 13(3):381-9. DOI: 10.1111/j.1365-2753.2006.00711.x. View

Khan A, AlRuthia Y, Balkhi B, Alghadeer S, Temsah M, Althunayyan S . Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia. Int J Environ Res Public Health. 2020; 17(20). PMC: 7602112. DOI: 10.3390/ijerph17207458. View

Polgreen L, Brooks J . Estimating incremental costs with skew: a cautionary note. Appl Health Econ Health Policy. 2012; 10(5):319-29. PMC: 4745583. DOI: 10.2165/11632430-000000000-00000. View

John D, Narassima M, Menon J, Rajesh J, Banerjee A . Estimation of the economic burden of COVID-19 using disability-adjusted life years (DALYs) and productivity losses in Kerala, India: a model-based analysis. BMJ Open. 2021; 11(8):e049619. PMC: 8375445. DOI: 10.1136/bmjopen-2021-049619. View

10.

Pagano E, Petrelli A, Picariello R, Merletti F, Gnavi R, Bruno G . Is the choice of the statistical model relevant in the cost estimation of patients with chronic diseases? An empirical approach by the Piedmont Diabetes Registry. BMC Health Serv Res. 2015; 15:582. PMC: 4696194. DOI: 10.1186/s12913-015-1241-1. View

11.

Wapner J . Covid-19: Medical expenses leave many Americans deep in debt. BMJ. 2020; 370:m3097. DOI: 10.1136/bmj.m3097. View

12.

Salcedo-Mejia F, Alvis-Zakzuk N, Carrasquilla-Sotomayor M, Redondo H, Castaneda-Orjuela C, De la Hoz-Restrepo F . Economic Cost of Severe Acute Respiratory Infection Associated to Influenza in Colombian Children: A Single Setting Analysis. Value Health Reg Issues. 2019; 20:159-163. DOI: 10.1016/j.vhri.2019.07.010. View

13.

Cutler D, Summers L . The COVID-19 Pandemic and the $16 Trillion Virus. JAMA. 2020; 324(15):1495-1496. PMC: 7604733. DOI: 10.1001/jama.2020.19759. View